Overview

Efficacy and Safety of Prophylactic Use of an Antibiotic for Medical Thoracoscopy

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
0
Participant gender:
All
Summary
This is a prospective study to assess the efficacy and safety of a single dose of cefazolin 2g IV for the prophylaxis of surgical site and pleural space infections in patients undergoing medical thoracoscopy.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Postgraduate Institute of Medical Education and Research
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Cefazolin
Clindamycin
Clindamycin palmitate
Clindamycin phosphate
Criteria
Inclusion Criteria:

1. Age ≥12 years

2. Medical thoracoscopy being performed for a pleural effusion for any of the three
indications: diagnosis, pleurodesis, or adhesiolysis

Exclusion Criteria:

1. Age ≥80 years

2. Pao2/FIO2< 300;

3. Hemodynamic instability

4. Myocardial infarction or unstable angina in the last 6 wk

5. Lack of pleural space due to adhesions

6. Uncorrected coagulopathy

7. Failure to provide informed consent

8. Patients already taking any antibiotic due to any reason